Morgan Stanley’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.1K Buy
72,226
+70,543
+4,192% +$43K ﹤0.01% 6401
2025
Q1
$1.27K Sell
1,683
-6,242
-79% -$4.71K ﹤0.01% 7251
2024
Q4
$7.62K Sell
7,925
-260,984
-97% -$251K ﹤0.01% 6889
2024
Q3
$387K Sell
268,909
-848,096
-76% -$1.22M ﹤0.01% 5520
2024
Q2
$1.35M Sell
1,117,005
-2,950,300
-73% -$3.57M ﹤0.01% 4795
2024
Q1
$9.56M Sell
4,067,305
-1,530,313
-27% -$3.6M ﹤0.01% 3384
2023
Q4
$10.6M Buy
5,597,618
+1,761,241
+46% +$3.33M ﹤0.01% 3865
2023
Q3
$5.26M Buy
3,836,377
+1,388,534
+57% +$1.9M ﹤0.01% 3701
2023
Q2
$5.95M Buy
2,447,843
+807,965
+49% +$1.96M ﹤0.01% 3637
2023
Q1
$9.45M Buy
1,639,878
+7,824
+0.5% +$45.1K ﹤0.01% 3201
2022
Q4
$14.6M Sell
1,632,054
-28,623
-2% -$256K ﹤0.01% 2660
2022
Q3
$23.6M Buy
1,660,677
+26,940
+2% +$383K ﹤0.01% 2020
2022
Q2
$23.9M Buy
1,633,737
+1,618,781
+10,824% +$23.6M ﹤0.01% 2088
2022
Q1
$299K Buy
14,956
+621
+4% +$12.4K ﹤0.01% 5698
2021
Q4
$250K Sell
14,335
-1,243
-8% -$21.7K ﹤0.01% 5949
2021
Q3
$123K Buy
15,578
+646
+4% +$5.1K ﹤0.01% 6251
2021
Q2
$154K Buy
14,932
+14,456
+3,037% +$149K ﹤0.01% 6142
2021
Q1
$6K Sell
476
-15,315
-97% -$193K ﹤0.01% 7052
2020
Q4
$222K Buy
15,791
+6,121
+63% +$86.1K ﹤0.01% 5538
2020
Q3
$115K Buy
9,670
+7,268
+303% +$86.4K ﹤0.01% 5358
2020
Q2
$36K Sell
2,402
-117,850
-98% -$1.77M ﹤0.01% 5792
2020
Q1
$867K Sell
120,252
-92,978
-44% -$670K ﹤0.01% 4054
2019
Q4
$2.22M Buy
213,230
+205,520
+2,666% +$2.14M ﹤0.01% 3953
2019
Q3
$477K Buy
7,710
+6,137
+390% +$380K ﹤0.01% 4702
2019
Q2
$113K Sell
1,573
-2,472
-61% -$178K ﹤0.01% 5266
2019
Q1
$193K Sell
4,045
-2,846
-41% -$136K ﹤0.01% 5082
2018
Q4
$415K Sell
6,891
-2,061
-23% -$124K ﹤0.01% 4898
2018
Q3
$948K Sell
8,952
-3,605
-29% -$382K ﹤0.01% 4577
2018
Q2
$804K Buy
12,557
+10,459
+499% +$670K ﹤0.01% 4766
2018
Q1
$141K Buy
+2,098
New +$141K ﹤0.01% 5606